VF Partners with Northwestern University to Open Vasculitis Program

The Vasculitis Foundation and Northwestern Memorial Hospital’s Division of Rheumatology have launched the health system’s first Vasculitis Clinical Research Program. Vasculitis is an immune system disorder that causes destructive inflammation of the blood vessels, including arteries, veins, and capillaries. It is estimated about 1 in 3,300 people suffer from vasculitis. While there are several types of vasculitis, each type is categorized by the size of the blood vessel affected.

The Vasculitis Clinical Research Program at Northwestern Memorial Hospital will provide comprehensive care for patients with vasculitis and supports clinical and translational research into the epidemiology and treatment of these diseases. The clinic will offer patients coordinated care by a variety of clinical specialists including pulmonary disease, renal disease, dermatology, otorhinolaryngology, and other disciplines involved in vasculitis care.

Karen Hirsch, President of the VF Board of Directors, says the new center exemplifies how organizations can work together. “The collaboration with Northwestern is an exciting new way that the Vasculitis Foundation is addressing the needs of those with vasculitis,” says Hirsch. “It is important for residents in the Chicagoland area to have this resources, and it will serve as a model for future collaborations.”


Amy Archer, MD, PhD

Dr. Amy Archer, a rheumatologist at Northwestern Memorial Hospital, was named director of the new Vasculitis Clinical Research Program recently.

“We know that early and accurate diagnosis is critical for avoiding permanent damage to vital organs and blood vessels affected by vasculitis. It’s imperative that patients have a comprehensive care center that can help accurately identify and treat the disease,” says Archer. “This unique collaboration allows us to grow a strong research and training program that will drive advancements in the treatment of this disease for our patients.”

About Northwestern Medicine

Vasculitis Foundation

The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.

#GivingTuesday Matching Gift Challenge

#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.  This year your donation can go even further with our generous matching gift challenge! more »

Introducing our 2017-2018 VCRC-VF Fellow

Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship.  She received her medical degree from New York Medical College in Valhalla, New York.   She completed her Internal Medicine more »

FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of more »

Brandon Hudgins to Receive NORD Rare Impact Award at May 18th Ceremony

On  Thursday, May 18,  Brandon Hudgins will be accepting the NORD 2017 Rare Impact Award.   The VF  nominated Brandon, a record-breaking, elite runner, for his work raising awareness about more »

Vasculitis Update 2017 CME Course: Chicago, June 24

The Vasculitis Foundation is pleased to present the 2017 Vasculitis Update CME Course for health care professionals in partnership with Northwestern Division of Rheumatology on Saturday, June 24, 2017 from 7:45 more »